Substituted uracils as chymase inhibitors

US9695131B2 · kind B2 · utility

Assignee

• Bayer Pharma Aktiengesellschaft · DE

Inventors

• Chantal Fürstner · Neheim, DE
• Jens Ackerstaff · Mülheim an der Ruhr, DE
• Alexander Straub · Wuppertal, DE
• Heinrich Meier · Wuppertal, DE
• Hanna Tinel · Wuppertal, DE
• Katja Zimmermann · Mülheim an der Ruhr, DE
• Dmitry Zubov · Remscheid, DE
• Jens Schamberger · Neviges, DE

Key dates

• Filing date: Nov 5, 2014
• Grant date: Jul 4, 2017
• Expiry date: Nov 5, 2034

Classification

• Technology area (CPC C): Chemistry; Metallurgy
• CPC primary: C07D417/14
• WIPO field: Pharmaceuticals
• WIPO sector: Chemistry

Abstract

Substituted uracil derivatives of formula (I), processes for their preparation, their use alone or in combinations for the treatment and/or prophylaxis of diseases, and their use for preparing medicaments for the treatment and/or prophylaxis of diseases.